ES2154265T3 - Tratamiento de la disenteria bacteriana. - Google Patents

Tratamiento de la disenteria bacteriana.

Info

Publication number
ES2154265T3
ES2154265T3 ES92922817T ES92922817T ES2154265T3 ES 2154265 T3 ES2154265 T3 ES 2154265T3 ES 92922817 T ES92922817 T ES 92922817T ES 92922817 T ES92922817 T ES 92922817T ES 2154265 T3 ES2154265 T3 ES 2154265T3
Authority
ES
Spain
Prior art keywords
treatment
disenteria
bacterial
gal
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92922817T
Other languages
English (en)
Inventor
Glen D Armstrong
R Murray Ratcliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synsorb Biotech Inc
Original Assignee
Synsorb Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synsorb Biotech Inc filed Critical Synsorb Biotech Inc
Application granted granted Critical
Publication of ES2154265T3 publication Critical patent/ES2154265T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTAN COMPOSICIONES DE DIAGNOSTICO Y DE USO TERAPEUTICO QUE COMPRENDEN LA SUBUNIDAD (ALFA)GAL(1-4)(BETA)GAL. ESTAS COMPOSICIONES PERMITEN LA RAPIDA DIAGNOSIS Y EL TRATAMIENTO DE LAS INFECCIONES ENTERICAS PROVOCADAS POR EL "E. COLI" QUE PRODUCE TOXINAS SIMILARES A "SHIGA" (SLT).
ES92922817T 1991-10-18 1992-10-19 Tratamiento de la disenteria bacteriana. Expired - Lifetime ES2154265T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77873291A 1991-10-18 1991-10-18

Publications (1)

Publication Number Publication Date
ES2154265T3 true ES2154265T3 (es) 2001-04-01

Family

ID=25114261

Family Applications (2)

Application Number Title Priority Date Filing Date
ES92922817T Expired - Lifetime ES2154265T3 (es) 1991-10-18 1992-10-19 Tratamiento de la disenteria bacteriana.
ES00101263T Pending ES2150888T1 (es) 1991-10-18 1992-10-19 Diagnosis y tratamiento de la disenteria bacteriana.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES00101263T Pending ES2150888T1 (es) 1991-10-18 1992-10-19 Diagnosis y tratamiento de la disenteria bacteriana.

Country Status (9)

Country Link
US (3) US5620858A (es)
EP (2) EP1018342A3 (es)
AT (1) ATE198991T1 (es)
CA (1) CA2121604C (es)
DE (2) DE1018342T1 (es)
DK (1) DK0610356T3 (es)
ES (2) ES2154265T3 (es)
GR (1) GR3035665T3 (es)
WO (1) WO1993008209A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2154265T3 (es) * 1991-10-18 2001-04-01 Synsorb Biotech Inc Tratamiento de la disenteria bacteriana.
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea
US5637576A (en) * 1995-06-05 1997-06-10 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5627163A (en) * 1995-06-05 1997-05-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5661131A (en) * 1995-06-05 1997-08-26 Synsorb Biotech, Inc. Treatment of cholera
US5811409A (en) * 1995-06-05 1998-09-22 Synsorb Biotech, Inc. Treatment of cholera
US6069137A (en) * 1996-03-11 2000-05-30 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5891860A (en) * 1996-03-11 1999-04-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
IL127649A0 (en) * 1996-06-21 1999-10-28 Synsorb Biotech Inc Use of oligosaccharides for neutralising e. coli toxins
JPH107575A (ja) * 1996-06-21 1998-01-13 Synsorb Biotec Inc 細菌性赤痢の処置
US5846943A (en) * 1996-11-08 1998-12-08 Synsorb Biotech, Inc. Solid support matricles containing a toxin binding oligosaccharide
US6013634A (en) * 1996-11-08 2000-01-11 Synsorb Biotech, Inc. Solid support matrices containing a toxin binding oligosaccharide
US5910579A (en) * 1997-01-10 1999-06-08 Synsorb Biotech Inc. Processes for the preparation of αGal(1->4)βGal (1->4) Glc-OR
US5888750A (en) * 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
ZA991410B (en) 1998-02-23 1999-10-06 Synsorb Biotech Inc Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
WO1999053320A1 (en) 1998-04-15 1999-10-21 Utah State University Real time detection of antigens
US7220596B2 (en) * 1998-04-15 2007-05-22 Utah State University Real time detection of antigens
US5962423A (en) * 1998-08-07 1999-10-05 The Governors Of The University Of Alberta Treatment of bacterial dysentery
US6310043B1 (en) 1998-08-07 2001-10-30 Governors Of The University Of Alberta Treatment of bacterial infections
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US20060051440A1 (en) * 2002-09-10 2006-03-09 Joel Moss Factors that bind intestinal toxins
BE1019290A5 (nl) 2010-04-14 2012-05-08 Nutrition Sciences Nv Sa Voedingsupplement omvattende oligosachariden en middellange keten vetzuren.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016702B1 (fr) * 1979-03-16 1985-02-20 Institut Merieux Médicament, notamment pour le traitement du choléra, et compositions pharmaceutiques le contenant
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
US4946943A (en) * 1985-06-20 1990-08-07 Will Bloch Purification of ribotoxins and their conjugates
US4863852A (en) * 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US5168063A (en) * 1990-07-27 1992-12-01 Wisconsin Alumni Research Foundation Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11
ES2154265T3 (es) * 1991-10-18 2001-04-01 Synsorb Biotech Inc Tratamiento de la disenteria bacteriana.
AU667533B2 (en) * 1992-03-26 1996-03-28 Microcarb, Inc. Monospecific polyclonal antibodies to shiga-like toxins
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea

Also Published As

Publication number Publication date
CA2121604C (en) 2002-01-15
DE69231675T2 (de) 2001-06-28
US5679653A (en) 1997-10-21
EP0610356A4 (en) 1995-03-29
EP0610356B1 (en) 2001-01-31
DE1018342T1 (de) 2001-01-11
EP0610356A1 (en) 1994-08-17
WO1993008209A1 (en) 1993-04-29
ATE198991T1 (de) 2001-02-15
EP1018342A2 (en) 2000-07-12
DE69231675D1 (de) 2001-03-08
US5620858A (en) 1997-04-15
ES2150888T1 (es) 2000-12-16
DK0610356T3 (da) 2001-02-19
US5955449A (en) 1999-09-21
EP1018342A3 (en) 2001-04-11
CA2121604A1 (en) 1993-04-29
GR3035665T3 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
ES2154265T3 (es) Tratamiento de la disenteria bacteriana.
ES2056963T3 (es) Agentes antibacterianos.
ES2137162T3 (es) Cefalosporinas y homologos, preparaciones y composiciones farmaceuticas.
ATE30237T1 (de) Epi-derivat von azahomoerythromycin a und zwischenprodukte.
NO933077D0 (no) Anvendelse av il-4-reseptor for terapi i profylakse og diagnostikk av allergiske, virale og parasitiske og bakterielle sykdommer
ATE74508T1 (de) Azithromycin und seine derivate als antiprotozoenmittel.
NL300224I1 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
ATE190064T1 (de) Kombination therapeutische nukleoside mit weiteren therapeutisch wirksamen komponenten.
ATE75752T1 (de) Antibiotikum.
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
EP1037650A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS
DE68918944D1 (de) Künstliche rezeptor-analoge.
PH27568A (en) Lactamimides in the treatment of drug-resistant protozoal infections
ATE203246T1 (de) Dialkyltiacumicine
ATE134640T1 (de) Neue verbindungen, ''leusstroducsins'' gennant, ihre herstellung und therapeutische verwendungen
NO930884L (no) Antimikrobielle karbapenemderivater, samt fremgangsmaate til fremstilling og terapeutisk anvendelse derav
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
NO934655L (no) Legemiddel for gram-positive sykdommer i akvatiske arter
IT1276454B1 (it) Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico.
NO890287L (no) Fremstilling av beta-laktam-antibiotika.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 610356

Country of ref document: ES